%PDF-1.4
%
207 0 obj
<>
endobj
209 0 obj
<>stream
2016-02-23T09:36:28-05:00
2016-04-18T14:56:10-07:00
2016-04-18T14:56:10-07:00
itext-paulo-155 (itextpdf.sf.net-lowagie.com)
application/pdf
Development of ASG-15ME, a Novel Antibody Drug Conjugate Targeting SLITRK6, a New Urothelial Cancer Biomarker
uuid:04e0669a-1dd2-11b2-0a00-1a0a279d8f00
uuid:04e0669e-1dd2-11b2-0a00-b30000000000
endstream
endobj
201 0 obj
<>
endobj
1 0 obj
<>
endobj
210 0 obj
<>
endobj
211 0 obj
<>
endobj
212 0 obj
<>
endobj
12 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
13 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
14 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
15 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
16 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
17 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
18 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
19 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
20 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
21 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
22 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
23 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
24 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
25 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
26 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
27 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
28 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
29 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
30 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
31 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
32 0 obj
<>/MediaBox[0 0 720 540]/Parent 212 0 R/Resources<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/XObject<>>>/StructParents 0/Tabs/S/Type/Page>>
endobj
33 0 obj
<>/MediaBox[0 0 720 540]/Parent 212 0 R/Resources<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/StructParents 0/Tabs/S/Type/Page>>
endobj
34 0 obj
<>/MediaBox[0 0 720 540]/Parent 212 0 R/Resources<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/StructParents 0/Tabs/S/Type/Page>>
endobj
35 0 obj
<>/MediaBox[0 0 720 540]/Parent 212 0 R/Resources<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/StructParents 0/Tabs/S/Type/Page>>
endobj
213 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
283 0 obj
[289 0 R 290 0 R 291 0 R 292 0 R 293 0 R 294 0 R]
endobj
284 0 obj
<>stream
q
538.6593933 0 0 78.7513733 36.6703033 665.2486267 cm
/Im0 Do
Q
BT
/T1_0 1 Tf
10 0 0 10 107.23972 566.99985 Tm
( Published OnlineFirst March 4, 2016.)Tj
/T1_1 1 Tf
-7.72397 0 Td
(Mol Cancer Ther\240)Tj
/T1_0 1 Tf
0 1 TD
(\240 )Tj
0 1.00001 TD
(Kendall Morrison, Pia M. Challita-Eid, Arthur Raitano, et al. )Tj
/T1_2 1 Tf
0 1 TD
(\240 )Tj
/T1_3 1 Tf
18 0 0 18 30 606.99997 Tm
(Targeting SLITRK6, a New Urothelial Cancer Biomarker)Tj
T*
(Development of ASG-15ME, a Novel Antibody Drug Conjugate)Tj
ET
30 446 552 101 re
0 0 m
S
BT
/T1_0 1 Tf
11 0 0 11 120.94202 519.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-7.55696 1 Td
(Updated version)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 141 511.99994 Tm
(\240 )Tj
/T1_0 1 Tf
16.73095 1 Td
( )Tj
0 0 1 rg
-15.11896 0 Td
(10.1158/1535-7163.MCT-15-0570)Tj
0 g
-1.61199 0 Td
(doi:)Tj
0 1.00001 TD
(Access the most recent version of this article at:)Tj
ET
BT
/T1_0 1 Tf
11 0 0 11 120.94202 478.99994 Tm
(\240 )Tj
/T1_3 1 Tf
-3.50099 1 Td
(Material)Tj
-3.44499 1.00001 Td
(Supplementary)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 141 481.99994 Tm
(\240 )Tj
/T1_0 1 Tf
39.01791 1 Td
( )Tj
0 0 1 rg
-39.01791 0 Td
(http://mct.aacrjournals.org/content/suppl/2016/03/04/1535-7163.MCT-15-05\
70.DC1.html)Tj
0 g
T*
(Access the most recent supplemental material at:)Tj
ET
BT
/T1_0 1 Tf
11 0 0 11 120.94202 445.99994 Tm
(\240 )Tj
/T1_3 1 Tf
-5.05597 1 Td
(Manuscript)Tj
2.05699 1.00001 Td
(Author)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 141 458.99997 Tm
(edited. )Tj
0 1 TD
(Author manuscripts have been peer reviewed and accepted for publication \
but have not yet been)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 30 425.99997 Tm
(\240 )Tj
T*
(\240 )Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 30 405.99997 Tm
(\240 )Tj
T*
(\240 )Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 30 385.99997 Tm
(\240 )Tj
T*
(\240 )Tj
ET
30 291 552 95 re
0 0 m
S
BT
/T1_0 1 Tf
11 0 0 11 120.94202 353.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-5.66901 1 Td
(E-mail alerts)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 295.4996 366 Tm
( related to this article or journal.)Tj
0 0 1 rg
-15.44996 0 Td
(Sign up to receive free email-alerts)Tj
ET
BT
0 g
/T1_0 1 Tf
11 0 0 11 120.94202 320.99994 Tm
(\240 )Tj
/T1_3 1 Tf
-6.38997 1 Td
(Subscriptions)Tj
0.556 1.00001 Td
(Reprints and )Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 141 323.99994 Tm
(\240 )Tj
13.46496 1 Td
(.)Tj
0 0 1 rg
-6.85098 0 Td
(pubs@aacr.org)Tj
0 g
-6.61398 0 Td
(Department at)Tj
0 1.00001 TD
(To order reprints of this article or to subscribe to the journal, contac\
t the AACR Publications)Tj
ET
BT
/T1_0 1 Tf
11 0 0 11 120.94202 298.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-5.66901 1 Td
(Permissions)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 141 290.99994 Tm
(\240 )Tj
16.63094 1 Td
(.)Tj
0 0 1 rg
-10.01696 0 Td
(permissions@aacr.org)Tj
0 g
-6.61398 0 Td
(Department at)Tj
T*
(To request permission to re-use all or part of this article, contact the\
AACR Publications)Tj
ET
BT
/T1_0 1 Tf
9 0 0 9 243.89888 11 Tm
(on April 18, 2016. \251 2016 American Association for Cancer Research. )Tj
0 0 1 rg
-9.33597 0 Td
(mct.aacrjournals.org )Tj
0 g
-8.11397 0 Td
(Downloaded from )Tj
ET
BT
/T1_0 1 Tf
9 0 0 9 96.63571 769.99997 Tm
(Author manuscripts have been peer reviewed and accepted for publication \
but have not yet been edited. )Tj
1.05852 1 Td
(Author Manuscript Published OnlineFirst on March 4, 2016; DOI: 10.1158/1\
535-7163.MCT-15-0570 )Tj
ET
endstream
endobj
288 0 obj
<>/Filter/FlateDecode/Height 225/Length 77819/Name/X/Subtype/Image/Type/XObject/Width 1539>>stream
HMW~ݏ0F0n
$&QK4CBܸ4A6Ꞅ%gg7@Mݔ,Y -$Z2cl M$s|;M[sxs>fqD ԝ "u *H)
"Rw
ԝ "u *H)
"Rw
ԝ "u *H)
"Rw
ԝ "u *H)
"Rw
ԝ "u *H)
"Rw
ԝ "u *H)
"Rw
ԝ "u *H)
"Rw
ԝ "u *H)
"Rw
MyA}Oeqk(qgQJF|E(ǭnJxȥP;k84MG ȳ,cDtap \';~&."qi "M($y0nIą.
h0Ί$쬱uOZpqyY{E@
=XY[X7ިb8tOZ>ͳ8NQ6iцfi'+mڗkyڤ>qeߺ>C,O;K5~/dx2{'F)*m ~+^^lu~N'I}jyLʲ,Ѧ(v|(Voۻt=x-Zݷoߎ/<1Axj|"¨"
B?+q/_sÇu4Mmv9==}v[ǿ/-LHhC7x)gI1tTB7]y877|14 ]b:zdv2p֍jv}mu6ܢ8C|GiT9UGh=y[[
Y@KЁg/ͦVjgGm3PwS7
"(Ȳ5 7oj>lMUm_Z\ 9_ӭVK#`ffŋÚ(\Oafy(T5mWF;sٳgoݺ[¦MښyD-~A6no8vؑ#G1\Ci~w4lV/ϋ8,qVk5"fܚhuܼ{xnjnt&.
ֵzW!~lJ0C=m{VںUA>|XvvVʕM6{ʏ*ءq%kgyxXOJ:oҲOFO;h7[6i9{`dXj7m҂^*m~~~iii6ϳW g@4vKy鹭U$I|]uh3?`Uמi}_ݻ099v}?55%0]jMfࢳK4~w͓'O~0A'7ot:װZОZeMGYzЩSZt5?|'?XlF#$ay
)Kkz~?OڮU.,7]Vc(O?fv|jnnNfvv~.Ϩ|=kcVZ:pxJSj{p]KU[:[a렓D|5Odڵ^v}rZoz7N8a_=Z[Y. O /Sq?z啷~֗_x4"mBsaCU˟9KΝ{رCt:ijk𣿽.p{KݣG|ejj
:e/MA0ѡ4*,K/V;@m! !ZED0Fb&hD@Xn+.YDiӟq|yߏ[MSNb-qDƍ)&tqg6kX,cMBe䬅ymu_RF
?2 ?>hn0)bJRi`%Gbh;L&Ş/|N>[8\/
G
}1ucwkjjpET"=1t\.ゖT*$Nq]]/&惰00c[C``8 >644xxxjmmőf::[y*ӧOLE%@ցxyyNFSQQQcSzcCùئѹCĪ9H((((((((((((((gv֖I&1#SV٣
'K^#GeFT*~^r%$$d& qM[?}k[={즦&ooo4 jubaQ0kbL&3
8kFy!UUU666ܜƾV'pF;^+hl9P fŠ&I*ϝEl5jr*R9m4uoi('66=R;swtunڴAAAOT$Yti}}=_C.;v 22ν}}}aaaHgAQu|||FF&dڵhϞ=I Pu& b+3twvvw\tiʕܹsqqqh=s̝;wzyyBE&|d\m&N>pA6oaZ
p|rJJJgg'{n0(HӍmxxYdʔ32߿D> -F.huVnΜ9ee[`PPPPPPPPPPPPPP&V>>}}e9M`/ NvĎ5
J
`hoop;w@5 +U{11_7:AC8TB'B57^$,XVfYt]O[|e]]Z-!}6kYYYttdu۟7l zŴˮ_~zHCU,4JJJ?Kq͛?~HoŜ۷S""hQeU劏W$%%iZUj{2쫋ݒk!̙3,@f_O~I\\\]]]QQ_/^rlܸqyYY[T:9˗C\82 J8Q͡oN+u9AE{F(//Hifͺwnzz:f/##-^vqs35'O?~C@outt@e*** H||U*4c:ujiOOD²l3]bf8:;L&3Y˱cq\׳N???lmp*k4W:S0RGGJDv9B++|ʚޓAJ:e|Q䠠 $3caYw
:cyyy^^wuJwBhkkt_|EZzU1.93د3zn6I6*aH
aD-%FaTbT R
de,Q7v@b 4}ޜjg4=u_|m4Yxӕqwǂ|-$Y[!t)-e.M{Ͻe+I)a@iiݰyDӾJ,00!8
999]|9 `tt"666)) XUիWMMMutu=koH$͛7c7`;o֭ΜfʕF&p|bCBB`5 pVVVQQQ8A;wAɪ*0@fÆ
23̲,`7n_rrSSSz1?DD `}}ğBQX̖` *-@Cyf}D!B"D!B